-
BMS inks drug discovery deal with Schr?dinger
pharmatimes
November 25, 2020
Bristol Myers Squibb will pay $55m upfront to American life sciences company Schr?dinger to access its drug discovery platform.
-
Twist Bioscience announces strategic collaboration with Schr?dinger for drug discovery
pharmaceutical-business-review
January 19, 2020
Twist Bioscience, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced a collaboration with Schr?dinger, a company focused on transforming the way therapeutics are discovered with
-
Schr?dinger, Bayer collaborate to co-develop de novo design technology to accelerate drug discovery
americanpharmaceuticalreview
January 13, 2020
Schr?dinger and Bayer announced a five-year technology alliance to develop a comprehensive de novo design solution with the objective to accelerate the discovery of innovative high-quality drugs.
-
Schr?dinger, AstraZeneca join hands to accelerate drug dicovery
biospectrumasia
September 05, 2019
Schr?dinger’s platform will be used by AstraZeneca’s medicinal and computational chemists
-
Schr?dinger Expands Drug Discovery Partnership with Morphic Therapeutic
americanpharmaceuticalreview
August 14, 2019
chr?dinger announced an expansion of its computational design collaboration with Morphic Therapeutic, a biotechnology company focused on developing a new class of oral small-molecule integrin-targeted therapeutics that Schr?dinger co-founded with ...
-
Schr?dinger raises $110m to develop drug discovery platform
pharmaceutical-technology
May 22, 2019
Schr?dinger has raised $110m during a funding round to develop its computational platform, which combines physics-based molecular simulations and machine learning for the exploration of chemical space.
-
Schr?dinger and SPARC announce collaboration to accelerate neurodegeneration drug development program
expressbpd
December 04, 2018
Collaboration brings together Schr?dingers in silico discovery capabilities with SPARC’s novel insights into CNS pathways to speed drug development
-
Schr?dinger, WuXi AppTec Enter Drug Discovery Tie-up
contractpharma
November 12, 2018
Schr?dinger, WuXi AppTec Enter Drug Discovery Tie-up
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight January 2025
